These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 34058741)

  • 1. Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients.
    Unda SR; Antoniazzi AM; Altschul DJ; Marongiu R
    Dement Geriatr Cogn Disord; 2021; 50(2):143-152. PubMed ID: 34058741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
    Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
    Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's.
    Delvaux E; Mastroeni D; Nolz J; Chow N; Sabbagh M; Caselli RJ; Reiman EM; Marshall FJ; Coleman PD
    Neurobiol Aging; 2017 Oct; 58():225-237. PubMed ID: 28716532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease and Parkinson Dementia Distinguished by Cognitive Marker.
    Kozlova I; Parra MA; Titova N; Gantman M; Sala SD
    Arch Clin Neuropsychol; 2021 Apr; 36(3):307-315. PubMed ID: 32101280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.
    Walker IM; Fullard ME; Morley JF; Duda JE
    Handb Clin Neurol; 2021; 182():317-329. PubMed ID: 34266602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.
    Goldman JG; Aggarwal NT; Schroeder CD
    Neurodegener Dis Manag; 2015 Oct; 5(5):425-43. PubMed ID: 26517759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between the behavioral and psychological symptoms of Alzheimer's disease and Parkinson's disease.
    Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K
    J Neurol Sci; 2016 Oct; 369():278-282. PubMed ID: 27653908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.